Clinical trial
Bioequivalence Study Of Bazedoxifene/Conjugated Estrogen Tablets In…
NCT00396799 · Wyeth is now a wholly owned subsidiary of Pfizer, Industry · Completed
Key facts
| NCT number | NCT00396799 |
|---|---|
| Title | Bioequivalence Study Of Bazedoxifene/Conjugated Estrogen Tablets In Postmenopausal Women |
| Official title | An Open-Label, Single-Dose, Randomized-to-Sequence, 2-Period, Crossover, Pivotal Bioequivalence Study Between Bazedoxifene Acetate/Conjugated Estrogens (Premarin Current Process) and Bazedoxifene Acetate/Conjugated Estrogens (Premarin New Process) Tablets Administered to Healthy Postmenopausal Women |
| Lead sponsor | Wyeth is now a wholly owned subsidiary of Pfizer, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Menopause |
| Intervention type | Drug |
| Interventions | bazedoxifene/conjugated estrogens |
| Start date | Nov 1, 2006 |
| Completion | Nov 1, 2006 |
| First posted | Nov 8, 2006 |
| Last update posted | Mar 13, 2007 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: